[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Angina Pectoris Drugs Market Report 2017

October 2017 | 101 pages | ID: UB0152DD6ACPEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Angina Pectoris Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Angina Pectoris Drugs in these regions, from 2012 to 2022 (forecast).
United States Angina Pectoris Drugs market competition by top manufacturers/players, with Angina Pectoris Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Gilead
  • Pfizer
  • Merck
  • Novartis
  • Mylan
  • AstraZeneca
  • Teva Pharmaceutical
  • Bayer HealthCare
  • Bristol-Myers Squibb
  • GlaxoSmithKline
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Calcium Channel Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Beta Blockers
  • Nitrates
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Angina Pectoris Drugs for each application, including
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Angina Pectoris Drugs Market Report 2017

1 ANGINA PECTORIS DRUGS OVERVIEW

1.1 Product Overview and Scope of Angina Pectoris Drugs
1.2 Classification of Angina Pectoris Drugs by Product Category
  1.2.1 United States Angina Pectoris Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Angina Pectoris Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Calcium Channel Blockers
  1.2.4 Angiotensin-Converting Enzyme Inhibitors
  1.2.5 Beta Blockers
  1.2.6 Nitrates
1.3 United States Angina Pectoris Drugs Market by Application/End Users
  1.3.1 United States Angina Pectoris Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Retail Pharmacies
  1.3.3 Hospital Pharmacies
  1.3.4 Online Pharmacies
1.4 United States Angina Pectoris Drugs Market by Region
  1.4.1 United States Angina Pectoris Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Angina Pectoris Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Angina Pectoris Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Angina Pectoris Drugs Status and Prospect (2012-2022)
  1.4.5 New England Angina Pectoris Drugs Status and Prospect (2012-2022)
  1.4.6 The South Angina Pectoris Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Angina Pectoris Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Angina Pectoris Drugs (2012-2022)
  1.5.1 United States Angina Pectoris Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Angina Pectoris Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES ANGINA PECTORIS DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Angina Pectoris Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Angina Pectoris Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Angina Pectoris Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Angina Pectoris Drugs Market Competitive Situation and Trends
  2.4.1 United States Angina Pectoris Drugs Market Concentration Rate
  2.4.2 United States Angina Pectoris Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Angina Pectoris Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ANGINA PECTORIS DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Angina Pectoris Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Angina Pectoris Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Angina Pectoris Drugs Price by Region (2012-2017)

4 UNITED STATES ANGINA PECTORIS DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Angina Pectoris Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Angina Pectoris Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Angina Pectoris Drugs Price by Type (2012-2017)
4.4 United States Angina Pectoris Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ANGINA PECTORIS DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Angina Pectoris Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Angina Pectoris Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANGINA PECTORIS DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Gilead
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Angina Pectoris Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Gilead Angina Pectoris Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Pfizer
  6.2.2 Angina Pectoris Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Pfizer Angina Pectoris Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Merck
  6.3.2 Angina Pectoris Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merck Angina Pectoris Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Novartis
  6.4.2 Angina Pectoris Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Novartis Angina Pectoris Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Mylan
  6.5.2 Angina Pectoris Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Mylan Angina Pectoris Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 AstraZeneca
  6.6.2 Angina Pectoris Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 AstraZeneca Angina Pectoris Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Teva Pharmaceutical
  6.7.2 Angina Pectoris Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Teva Pharmaceutical Angina Pectoris Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Bayer HealthCare
  6.8.2 Angina Pectoris Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bayer HealthCare Angina Pectoris Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Bristol-Myers Squibb
  6.9.2 Angina Pectoris Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Bristol-Myers Squibb Angina Pectoris Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 GlaxoSmithKline
  6.10.2 Angina Pectoris Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 GlaxoSmithKline Angina Pectoris Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 ANGINA PECTORIS DRUGS MANUFACTURING COST ANALYSIS

7.1 Angina Pectoris Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Angina Pectoris Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Angina Pectoris Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Angina Pectoris Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Angina Pectoris Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Angina Pectoris Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Angina Pectoris Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Angina Pectoris Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Angina Pectoris Drugs
Figure United States Angina Pectoris Drugs Market Size (MT) by Type (2012-2022)
Figure United States Angina Pectoris Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Calcium Channel Blockers Product Picture
Figure Angiotensin-Converting Enzyme Inhibitors Product Picture
Figure Beta Blockers Product Picture
Figure Nitrates Product Picture
Figure United States Angina Pectoris Drugs Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Angina Pectoris Drugs by Application in 2016
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure United States Angina Pectoris Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Angina Pectoris Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Angina Pectoris Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Angina Pectoris Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Angina Pectoris Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Angina Pectoris Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Angina Pectoris Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Angina Pectoris Drugs Sales (MT) and Growth Rate (2012-2022)
Figure United States Angina Pectoris Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Angina Pectoris Drugs Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Angina Pectoris Drugs Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Angina Pectoris Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Angina Pectoris Drugs Sales Share by Players/Suppliers
Figure 2017 United States Angina Pectoris Drugs Sales Share by Players/Suppliers
Figure United States Angina Pectoris Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Angina Pectoris Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Angina Pectoris Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Angina Pectoris Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Angina Pectoris Drugs Revenue Share by Players/Suppliers
Table United States Market Angina Pectoris Drugs Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market Angina Pectoris Drugs Average Price (USD/Kg) of Key Players/Suppliers in 2016
Figure United States Angina Pectoris Drugs Market Share of Top 3 Players/Suppliers
Figure United States Angina Pectoris Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Angina Pectoris Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Angina Pectoris Drugs Product Category
Table United States Angina Pectoris Drugs Sales (MT) by Region (2012-2017)
Table United States Angina Pectoris Drugs Sales Share by Region (2012-2017)
Figure United States Angina Pectoris Drugs Sales Share by Region (2012-2017)
Figure United States Angina Pectoris Drugs Sales Market Share by Region in 2016
Table United States Angina Pectoris Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Angina Pectoris Drugs Revenue Share by Region (2012-2017)
Figure United States Angina Pectoris Drugs Revenue Market Share by Region (2012-2017)
Figure United States Angina Pectoris Drugs Revenue Market Share by Region in 2016
Table United States Angina Pectoris Drugs Price (USD/Kg) by Region (2012-2017)
Table United States Angina Pectoris Drugs Sales (MT) by Type (2012-2017)
Table United States Angina Pectoris Drugs Sales Share by Type (2012-2017)
Figure United States Angina Pectoris Drugs Sales Share by Type (2012-2017)
Figure United States Angina Pectoris Drugs Sales Market Share by Type in 2016
Table United States Angina Pectoris Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Angina Pectoris Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Angina Pectoris Drugs by Type (2012-2017)
Figure Revenue Market Share of Angina Pectoris Drugs by Type in 2016
Table United States Angina Pectoris Drugs Price (USD/Kg) by Types (2012-2017)
Figure United States Angina Pectoris Drugs Sales Growth Rate by Type (2012-2017)
Table United States Angina Pectoris Drugs Sales (MT) by Application (2012-2017)
Table United States Angina Pectoris Drugs Sales Market Share by Application (2012-2017)
Figure United States Angina Pectoris Drugs Sales Market Share by Application (2012-2017)
Figure United States Angina Pectoris Drugs Sales Market Share by Application in 2016
Table United States Angina Pectoris Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Angina Pectoris Drugs Sales Growth Rate by Application (2012-2017)
Table Gilead Basic Information List
Table Gilead Angina Pectoris Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Gilead Angina Pectoris Drugs Sales Growth Rate (2012-2017)
Figure Gilead Angina Pectoris Drugs Sales Market Share in United States (2012-2017)
Figure Gilead Angina Pectoris Drugs Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Angina Pectoris Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer Angina Pectoris Drugs Sales Growth Rate (2012-2017)
Figure Pfizer Angina Pectoris Drugs Sales Market Share in United States (2012-2017)
Figure Pfizer Angina Pectoris Drugs Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Angina Pectoris Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Merck Angina Pectoris Drugs Sales Growth Rate (2012-2017)
Figure Merck Angina Pectoris Drugs Sales Market Share in United States (2012-2017)
Figure Merck Angina Pectoris Drugs Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Angina Pectoris Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novartis Angina Pectoris Drugs Sales Growth Rate (2012-2017)
Figure Novartis Angina Pectoris Drugs Sales Market Share in United States (2012-2017)
Figure Novartis Angina Pectoris Drugs Revenue Market Share in United States (2012-2017)
Table Mylan Basic Information List
Table Mylan Angina Pectoris Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Mylan Angina Pectoris Drugs Sales Growth Rate (2012-2017)
Figure Mylan Angina Pectoris Drugs Sales Market Share in United States (2012-2017)
Figure Mylan Angina Pectoris Drugs Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Angina Pectoris Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure AstraZeneca Angina Pectoris Drugs Sales Growth Rate (2012-2017)
Figure AstraZeneca Angina Pectoris Drugs Sales Market Share in United States (2012-2017)
Figure AstraZeneca Angina Pectoris Drugs Revenue Market Share in United States (2012-2017)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical Angina Pectoris Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Angina Pectoris Drugs Sales Growth Rate (2012-2017)
Figure Teva Pharmaceutical Angina Pectoris Drugs Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceutical Angina Pectoris Drugs Revenue Market Share in United States (2012-2017)
Table Bayer HealthCare Basic Information List
Table Bayer HealthCare Angina Pectoris Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bayer HealthCare Angina Pectoris Drugs Sales Growth Rate (2012-2017)
Figure Bayer HealthCare Angina Pectoris Drugs Sales Market Share in United States (2012-2017)
Figure Bayer HealthCare Angina Pectoris Drugs Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Angina Pectoris Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Angina Pectoris Drugs Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Angina Pectoris Drugs Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Angina Pectoris Drugs Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Angina Pectoris Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Angina Pectoris Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Angina Pectoris Drugs Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Angina Pectoris Drugs Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Angina Pectoris Drugs
Figure Manufacturing Process Analysis of Angina Pectoris Drugs
Figure Angina Pectoris Drugs Industrial Chain Analysis
Table Raw Materials Sources of Angina Pectoris Drugs Major Players/Suppliers in 2016
Table Major Buyers of Angina Pectoris Drugs
Table Distributors/Traders List
Figure United States Angina Pectoris Drugs Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Angina Pectoris Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Angina Pectoris Drugs Price (USD/Kg) Trend Forecast (2017-2022)
Table United States Angina Pectoris Drugs Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Angina Pectoris Drugs Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Angina Pectoris Drugs Sales Volume (MT) Forecast by Type in 2022
Table United States Angina Pectoris Drugs Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Angina Pectoris Drugs Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Angina Pectoris Drugs Sales Volume (MT) Forecast by Application in 2022
Table United States Angina Pectoris Drugs Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Angina Pectoris Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Angina Pectoris Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Angina Pectoris Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories